Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-DM1 with Palbociclib in Metastatic HER2+ Breast Cancer
NCT03530696Phase 2Completed
- Sponsor
- University of Arizona
- Start
- Dec 2018
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by University of Arizona. Started Dec 2018; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03530696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03530696.